1/5/2017 0 Comments Epigenetics Program NovartisAdvancing Epigenetics: . Jung holds an undergraduate degree in pharmacy and a Ph. D. He carried out postdoctoral studies in Canada at the University of Ottawa and was a lecturer and researcher, and then a senior researcher, in the Department of Pharmaceutical and Medicinal Chemistry at the University of M. Jung moved to the University of Freiburg, where he is currently a professor of pharmaceutical chemistry. His field of research is chemical epigenetics, focusing on drug discovery and assay development with inhibitors of histone deacetylases, NAD+- dependent histone deacetylases, histone acetyl- and methyltransferases, and histone demethylases. Margaret Porter Scott, Ph. D. Epizyme. Cambridge, MADr. Advancing Epigenetics. Novartis Institutes for. Sanders is the Editor for Custom Publishing for the journal Science and Program Director for. Porter Scott received her B. A. She is currently director of lead discovery at Epizyme responsible for enzymology, high throughput screening, and compound management. Porter Scott held scientific positions at Millennium, Neogenesis, Vertex, and Pfizer. Most recently, she spoke on biochemistry and screening approaches for histone methyl transferases at the 2. Society for Biomolecular Screening and 2. Society for Laboratory Automation meetings. Ji- Hu Zhang, Ph. D. Novartis Institutes for Bio. Medical Research. Cambridge, MADr. Zhang graduated from Nankai University in Tianjin, China, and received his Ph. Epigenetics, and cancer epigenetics in particular, is a bright spot in an otherwise stark biomedical-research funding and jobs landscape. Job Details: Novartis. The Novartis Next Generation Scientist Program The Novartis Next Generation Scientist Program is an intensive internship program for talented and. The Novartis Next Generation Scientist Program The Novartis Next Generation Scientist Program is an intensive internship program for talented and motivated research. Chromatin, Epigenetics and Cancer Charles W. Dana-Farber Cancer Institute Children’s Hospital Harvard Medical School. Epigenetics and Cancer (A4). Cancer epigenetics is a new and rapidly developing area of. Novartis Institutes for BioMedical Research, USA. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Epigenetics Program, Novartis Institutes for Biomedical. Open Innovation Case Study: Novartis Institutes for Biomedical Research (NIBR) . 2011 Novartis Institutes for Biomedical Research Page 2. 2nd Epigenetics in Drug Discovery – May 30-31, 2012 – Boston, MA chromatin from postmortem PFC across the lifespan and map the genome-wide distribution of. D. From 1. 99. 1 to 1. Dr. Zhang worked as a postdoctoral fellow in the Molecular and Cell Biology Department at the University of California- Berkeley and later in the Division of Chemistry at the California Institute of Technology. He started his industry career in 1. Affymax Research Institute as a research scientist before moving to Dupont Merck (later Du. Pont Pharmaceuticals) as a principal research scientist in the Leads Discovery Department. In 2. 00. 2, he joined Novartis as a research fellow in Leads Discovery Center, where he is currently a senior investigator. Zhang’s expertise is in biochemical and cellular assay development and high throughput screening (HTS) technologies for drug discovery. He also has a strong interest in the statistical aspects of HTS and was the senior contributor in the development of an assay quality statistical measure known as the Z’- factor. Zhang received the SBS Society Accomplishment Award in 2. Biomolecular Screening since 2. He has published over 3. Moderator: Sean Sanders, Ph. D. Science/AAASWashington, DCDr. Sanders did his undergraduate training at the University of Cape Town, South Africa, and his Ph. D. Following postdoctoral training at the National Institutes of Health and Georgetown University, Dr. Sanders joined Tran. Xeno. Gen, a startup biotechnology company in Massachusetts working on avian transgenics. Pursuing his parallel passion for writing and editing, Dr. Sanders joined Bio. Techniques as an editor, before joining Science/AAAS in 2. Sanders is the Editor for Custom Publishing for the journal Science and Program Director for Outreach.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |